×
About 42,165 results

ALLMedicine™ Venous Thromboembolism Center

Research & Reviews  19,409 results

Idarucizumab (PRADAXA®) as a sole reversal agent in an unstable hemorrhagic shock patie...
https://doi.org/10.1016/j.ajem.2021.01.086
The American Journal of Emergency Medicine; Kutner S, Scaturo N et. al.

Feb 22nd, 2021 - Dabigatran is a direct oral anticoagulant thrombin inhibitor approved for stroke prophylaxis in patients with non-valvular atrial fibrillation and prophylaxis or treatment of venous thromboembolism. Since approval, there has been increasing concer...

Potential risk factors for recurrent pulmonary embolism in hospitalized patients.
https://doi.org/10.21037/apm-21-36
Annals of Palliative Medicine; Wang L, Wang W et. al.

Feb 22nd, 2021 - Pulmonary embolism (PE) recurrence is the primary factor affecting the prognoses of patients with venous thromboembolism (VTE). However, the major challenge physicians face in these patients is the possible risk of PE recurrence after treatment. G...

Clinical Progress Note: Direct Oral Anticoagulants for Treatment of Venous Thromboembol...
https://doi.org/10.12788/jhm.3517
Journal of Hospital Medicine; Caldwell A, Moss S et. al.

Feb 22nd, 2021 - Clinical Progress Note: Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Children.|2021|Caldwell A,Moss S,Jenkins A,Herbst B,|

Leisure-time cross-country skiing and the risk of venous thromboembolism: A prospective...
https://doi.org/10.1177/2047487320908978
European Journal of Preventive Cardiology; Kunutsor SK, Lakka TA et. al.

Feb 21st, 2021 - Leisure-time cross-country skiing and the risk of venous thromboembolism: A prospective cohort study.|2021|Kunutsor SK,Lakka TA,Kurl S,Mäkikallio TH,Jae SY,|

see more →

Guidelines  183 results

2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy i...
https://doi.org/10.1016/j.jacc.2020.09.011
Journal of the American College of Cardiology; Kumbhani DJ, Cannon CP et. al.

Nov 30th, 2020 - 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Re...

Consensus-based clinical recommendations and research priorities for anticoagulant thro...
https://doi.org/10.1111/jth.15073
Journal of Thrombosis and Haemostasis : JTH REFERENCES; Goldenberg NA, Sochet A et. al.

Nov 11th, 2020 - Observational studies indicate that children hospitalized with COVID-19-related illness, like adults, are at increased risk for venous thromboembolism (VTE). A multicenter phase 2 clinical trial of anticoagulant thromboprophylaxis in children hosp...

Scientific and Standardization Committee communication: Clinical guidance on the diagno...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283841
Journal of Thrombosis and Haemostasis : JTH REFERENCES; Spyropoulos AC, Levy JH et. al.

May 27th, 2020 - Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.|2020|Spyropoulos AC,Levy JH,Ageno W,Connors JM,Hunt BJ,|adminis...

Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, manage...
https://doi.org/10.1136/bmj.m1565
BMJ (Clinical Research Ed.); McCormack T, Harrisingh MC et. al.

May 20th, 2020 - Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, management, and thrombophilia testing.|2020|McCormack T,Harrisingh MC,Horner D,Bewley S, ,|therapeutic use,standards,therapeutic use,drug therapy,epidemiology,therape...

Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for...
https://doi.org/10.1016/j.ajog.2020.04.032
American Journal of Obstetrics and Gynecology; , Pacheco LD et. al.

May 3rd, 2020 - Venous thromboembolism is a major cause of maternal morbidity and mortality. The risk of venous thromboembolism is particularly elevated during the postpartum period and especially after cesarean delivery. There is considerable variation in the ap...

see more →

Drugs  13 results see all →

Clinicaltrials.gov  20,669 results

Idarucizumab (PRADAXA®) as a sole reversal agent in an unstable hemorrhagic shock patie...
https://doi.org/10.1016/j.ajem.2021.01.086
The American Journal of Emergency Medicine; Kutner S, Scaturo N et. al.

Feb 22nd, 2021 - Dabigatran is a direct oral anticoagulant thrombin inhibitor approved for stroke prophylaxis in patients with non-valvular atrial fibrillation and prophylaxis or treatment of venous thromboembolism. Since approval, there has been increasing concer...

Potential risk factors for recurrent pulmonary embolism in hospitalized patients.
https://doi.org/10.21037/apm-21-36
Annals of Palliative Medicine; Wang L, Wang W et. al.

Feb 22nd, 2021 - Pulmonary embolism (PE) recurrence is the primary factor affecting the prognoses of patients with venous thromboembolism (VTE). However, the major challenge physicians face in these patients is the possible risk of PE recurrence after treatment. G...

Clinical Progress Note: Direct Oral Anticoagulants for Treatment of Venous Thromboembol...
https://doi.org/10.12788/jhm.3517
Journal of Hospital Medicine; Caldwell A, Moss S et. al.

Feb 22nd, 2021 - Clinical Progress Note: Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Children.|2021|Caldwell A,Moss S,Jenkins A,Herbst B,|

Leisure-time cross-country skiing and the risk of venous thromboembolism: A prospective...
https://doi.org/10.1177/2047487320908978
European Journal of Preventive Cardiology; Kunutsor SK, Lakka TA et. al.

Feb 21st, 2021 - Leisure-time cross-country skiing and the risk of venous thromboembolism: A prospective cohort study.|2021|Kunutsor SK,Lakka TA,Kurl S,Mäkikallio TH,Jae SY,|

see more →

News  1,891 results

ACC Issues Guidance on Antithrombotic Therapy
https://www.medscape.com/viewarticle/943139

Dec 22nd, 2020 - The American College of Cardiology (ACC) has released a new Expert Consensus Decision Pathway (ECDP) on the use of anticoagulant and antiplatelet therapy in patients with atrial fibrillation (AF) or venous thromboembolism (VTE) undergoing percutan...

What to Do When Anticoagulation Fails Patients With Cancer
https://www.medscape.com/viewarticle/941861

Dec 1st, 2020 - When a patient with cancer develops venous thromboembolism despite anticoagulation, how to help them comes down to clinical judgment, according to hematologist Neil Zakai, MD, associate professor at the University of Vermont, Burlington. "Unfortun...

Guidelines for Use of Inferior Vena Cava Filters in Treatment of Venous Thromboembolism (SIR, 2020)
https://reference.staging.medscape.com/viewarticle/941079

Nov 17th, 2020 - The guidelines on the use of inferior vena cava (IVC) filters in the treatment of patients with venous thromboembolism (VTE; ie, deep vein thrombosis [DVT] or pulmonary embolism [PE]) were published in October 2020 by the Society of Interventional...

Guidelines for Use of Inferior Vena Cava Filters in Treatment of Venous Thromboembolism (SIR, 2020)
https://reference.medscape.com/viewarticle/941079

Nov 17th, 2020 - The guidelines on the use of inferior vena cava (IVC) filters in the treatment of patients with venous thromboembolism (VTE; ie, deep vein thrombosis [DVT] or pulmonary embolism [PE]) were published in October 2020 by the Society of Interventional...

VTEs Tied to Immune Checkpoint Inhibitor Cancer Treatment
https://www.medscape.com/viewarticle/941143

Nov 16th, 2020 - Cancer patients who receive an immune checkpoint inhibitor have more than a doubled rate of venous thromboembolism during the subsequent 2 years, compared with their rate during the 2 years before treatment, according to a retrospective analysis o...

see more →